Nuclear Factor-&kgr;B: A Holy Grail in Cancer Prevention and Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|1|1|25-52

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.1, Iss.1, 2006-01, pp. : 25-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of childhood obesity: the new search for the holy grail?

By Reilly John J  

Future Lipidology, Vol. 2, Iss. 3, 2007-06 ,pp. : 271-276

Future Medicine

Access to resources Recommend Favorite

Combination therapy: the Holy Grail for the treatment of postmenopausal osteoporosis?

By Lewiecki E. Michael  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1493-1497

Informa Healthcare

Access to resources Recommend Favorite

Nuclear Expression of Glioma-Associated Oncogene Homolog 1 and Nuclear Factor-κB Is Associated with a Poor Prognosis of Pancreatic Cancer

By  

Oncology, Vol. 85, Iss. 2, 2013-07 ,pp. : 86-94

Karger

Access to resources Recommend Favorite

Clinicopathologic Significance of Nuclear Factor-κB and Vascular Endothelial Growth Factor Expression in Advanced Gastric Cancer Patients

By  

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-03 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-κB modulation in HepG2 hepatocarcinoma cells

By                

International Journal of Molecular Medicine, Vol. 28, Iss. 1, 2011-01 ,pp. : 25-31

Spandidos Publications

Access to resources Recommend Favorite